Search results
Bio. Dan currently serves on the Board of Directors of Southern Orthodontic Partners. In addition to serving on the Southern Orthodontics board, Dan is an Operating Partner at Welsh, Carson, Anderson, and Stowe. Previously, Dan served as President and CEO of Smile Brands, a privately held dental service organization with ~$500 million in ...
Dan Wechsler, M.D., Ph.D., Director of Pediatric Oncology at Aflac Cancer & Blood Disorders Center of Children’s Healthcare of Atlanta and Professor of Pediatrics at Emory University School of Medicine, had a passion for interest in cancer research that started when he was in college.
People also ask
Who is Daniel Wechsler?
Who is Dr Wechsler?
Who is David Wechsler?
Biography. Daniel S. Wechsler, MD, PhD, is the director of pediatric oncology at the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta. Dr. Wechsler comes to the Aflac Cancer Center having previously served as associate professor of pediatrics, and pharmacology and cell biology at Duke University School of Medicine.
December 2, 2019. Like. Wechsler is the former CEO of Smile Brands and senior executive at Bausch & Lomb, Merck and Pfizer. Dan Wechsler is the new Executive Chairman of NavaDerm Partners, a Northeast-focused dermatology services company and portfolio company of BelHealth Investment Partners, a New York-based healthcare private equity firm.
Dr. Dan Wechsler is one really busy — and sometimes bald — pediatric oncologist. Read on for more about this hardworking St. Baldrick’s researcher and everything he’s doing to help kids with cancer.
Dan Wechsler is Chairman at Navaderm Partners LLC. See Dan Wechsler's compensation, career history, education, & memberships.
Dec 2, 2019 · Dan is a highly experienced practice management leader and senior pharmaceutical executive. Previously, Dan served as President and CEO of Smile Brands, a privately held dental service organization with 4,500 employees (including 700 general and specialty dentists) and more than 360 offices.
